BRIEF-GREECE gives $36 million and fast-track designation to cell and gene JV

In GREECE, a joint venture (JV) between USA-based cell and gene therapy firm Orgenesis and Greek regenerative medicine company Theracell Advanced ...

READ THE ORIGINAL POST AT www.thepharmaletter.com